Achieve the Holy Grail of Nutritional, Health, & Immunological Human Breast Milk Benefits by Advancing the Development of Bioactive Ingredients with Regulatory Compliance
Infant nutrition is at an inflection point. In the wake of numerous global recalls linked to contaminated ingredients, the rollout of Operation Stork Speed, and rising social media scrutiny of ingredient safety, the spotlight on the formula industry has never been stronger.
As regulators tighten oversight and consumers demand greater transparency, the pressure is on to deliver bioactive ingredients that are not only clinically validated and scalable, but unquestionably safe and compliant. The race is on to bridge the nutritional, immunological, and functional gap between formula and human breast milk without compromising trust.
The 3rd Novel Ingredients for Infant Formula Summit returns in 2026 as the only industry-led forum dedicated to progressing infant nutrition innovation from R&D to approval and successful market entry. Uniting R&D leaders, ingredient innovators, manufacturers, food tech pioneers, academic KOLs, regulatory authorities, and commercial strategists, this is the only meeting purpose-built to tackle the full lifecycle of novel ingredient development in infant formula.
Across the program, 70+ experts from the likes of Bobbie Baby, Kendal Nutricare, Arla Foods and Novonesis will dive into deciphering submission pathways and global regulatory nuances, anticipating the impact of Operation Stork Speed, scaling next-generation bioactives including HMOs, lactoferrin, osteopontin, lysozyme, and specialty lipids, and overcoming formulation, stability, and clinical validation challenges.
Join the global infant formula community to unlock the next generation of safe, evidence-based bioactives and help define the future of infant nutrition innovation.
It was a wonderful event. Main positives in my opinion would be the small size of the conference and the concentrated focus of attendees, facilitating collaboration and networking.
Nicole Kaplan, Senior Lead, Helaina
The event was very well organized and was a wonderful opportunity to network with so many key people. The relevance of each of the speaker's talks were great and provided a wonderful update to important issues in our industry.
Joyce Stefan, Regional Sales & Account Manager, Arla Foods Ingredients
Good selection of industry and academic representatives. Good selection of topics. Good format that opened the opportunity for dialogue.
Vanessa Feher Castagna, Vice President - Research & Development, TurtleTree
Explore the Full Event Guide
- Discover 70+ R&D, regulatory, and commercial leaders from ingredient providers, infant formula manufacturers, foodtech innovators, academia, and government
- Preview 3 days of exclusive insights across novel bioactive discovery, clinical validation, regulatory approval pathways, formulation challenges
- Explore dedicated deep-dive workshops navigating evidence expectations in infant formulation, approval pathways & more
- Share easily with your team to assess and mobilize interest
Speakers
Official Partners
Attending Companies Include
Explore the Agenda
Discover forward-looking sessions on novel bioactives, clinical validation strategies, global regulatory pathways, formulation challenges, and commercial scale-up shaping the future of infant nutrition
Partner With Us
Connect with senior R&D, regulatory, and commercial leaders across ingredient providers, formula manufacturers, and foodtech companies seeking innovative, evidence-backed solutions to accelerate safe market entry
Join Industry Leaders
Network with decision-makers and innovators defining the next generation of clinically validated regulatory-ready ingredients designed to narrow the gap between formula and human breast milk